EP0032309A3 — Production of catalyst component, catalyst and use thereof
Assigned to Imperial Chemical Industries Ltd · Expires 1981-08-05 · 45y expired
What this patent protects
A catalyst component is a transition metal composition which is obtained by reacting together an inert particulate material, an organic magnesium compound, a halogen- containing compound such as carbon tetrachloride silicon tetrachloride or boron trichloride and a specified t…
USPTO Abstract
A catalyst component is a transition metal composition which is obtained by reacting together an inert particulate material, an organic magnesium compound, a halogen- containing compound such as carbon tetrachloride silicon tetrachloride or boron trichloride and a specified transition metal compound such as VOCl₃, bis(n-butoxy) titanium dich loride or zirconium tetrabenzyl. The catalyst component obtained can be used, together with an organic metal com pound, to give an olefin polymerisation catalyst. The catalyst can be used to effect the polymerisation of olefin monomers, for example, the copolymerisation of ethylene with an alpha-olefin monomer such as butene-1 in a fluidised bed reactor.
Drugs covered by this patent
- Azelex (AZELAIC ACID) · Leo Pharma As
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.